Revenue increased 13.3%
Revenue changed +13.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +13.3% from the comparable as-filed period.
Cash & equivalents changed +11.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +18.4% from the comparable as-filed period.
Inventory / revenue changed +210 basis points from the comparable as-filed period.
Selling, general & administrative changed +14.3% from the comparable as-filed period.
SBC / revenue changed -4 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +7.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.